Borgmann D, Ciglieri E, Biglari N, Brandt C, Cremer AL, Backes H, et al
The landscape of medical weight management in the United Kingdom has advanced rapidly, providing patients with more options than ever before
For instance, if you inject semaglutide in your abdomen one day, you might choose your thigh or upper arm the next time
Furthermore, GLP-1s also have been shown to reduce cardiovascular risks, as well as potentially providing a range of other health benefits for patients with chronic kidney disease, gastrointestinal disorders, neurodegenerative diseases and psychiatric disorders
Once multiple weight loss drugs come on the market, there will be some competition, and prices could moderate, said Rind, who is an internist at Beth Israel Deaconess Medical Center in Boston